Summary of Use during Lactation

Although no published data exist on the use of ipratropium, its use produces negligible maternal serum levels and any drug in breastmilk would not be absorbed by the infant. The risk to the breastfed infant of maternal ipratropium inhalation is small.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Albuterol, Salmeterol

Substance Name

Ipratropium

CAS Registry Number

60205-81-4

Drug Class

• Breast Feeding
• Lactation
• Anti-Asthmatic Agents
• Bronchodilator Agents
• Muscarinic Antagonists
• Parasympatholytics